We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

179 hedge funds and large institutions have $1.81B invested in Acorda Therapeutics in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $5.04M

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

19% more capital invested

Capital invested by funds: $1.52B → $1.81B (+$293M)

3% more funds holding

Funds holding: 174 → 179 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 68

Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
4.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
55
Reduced
68
Closed
20
Calls
$12.9M
Puts
$5.04M
Net Calls
+$7.88M
Net Calls Change
+$2.93M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$18.8M
2
VAM
Visium Asset Management
New York
+$18.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.86M
4
Charles Schwab
Charles Schwab
California
+$7.87M
5
BFA
BlackRock Fund Advisors
California
+$7.82M

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$29.3M
2
PHS
PFM Health Sciences
California
-$12.6M
3
MACM
March Altus Capital Management
Connecticut
-$10.3M
4
PCM
Penn Capital Management
Pennsylvania
-$9.32M
5
RFC
Russell Frank Company
Washington
-$6.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
176
Gemmer Asset Management
California
$3K – – –
RFA
177
Reilly Financial Advisors
California
$3K +$4.29K +1 New
Manulife (Manufacturers Life Insurance)
178
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.08K -$25.7K -6 -3%
FPFS
179
First Personal Financial Services
North Carolina
$1K – – –
LNB
180
Ledyard National Bank
$1K – – –
BRWA
181
B. Riley Wealth Advisors
Florida
$13 +$12.9K +3 New
MACM
182
March Altus Capital Management
Connecticut
– -$10.3M -2,529 Closed
AAP
183
Ardsley Advisory Partners
Connecticut
– -$5M -1,229 Closed
Marshall Wace
184
Marshall Wace
United Kingdom
– -$4.91M -1,209 Closed
Balyasny Asset Management
185
Balyasny Asset Management
Illinois
– -$4.38M -1,077 Closed
Jane Street
186
Jane Street
New York
– -$3.29M -808 Closed
ARTA
187
A.R.T. Advisors
New York
– -$1.82M -449 Closed
DCM
188
Driehaus Capital Management
Illinois
– -$1.76M -433 Closed
ACPU
189
Arrowgrass Capital Partners (US)
Delaware
– -$1.35M -333 Closed
TAM
190
THB Asset Management
Connecticut
– -$1.31M -323 Closed
HCM
191
Highbridge Capital Management
New York
– -$777K -191 Closed
CCIA
192
Campbell & Co Investment Adviser
Maryland
– -$733K -180 Closed
Bessemer Group
193
Bessemer Group
New Jersey
– -$718K -177 Closed
PP
194
Paloma Partners
Connecticut
– -$568K -140 Closed
PCM
195
Piermont Capital Management
Missouri
– -$325K -80 Closed
QT
196
Quantbot Technologies
New York
– -$298K -73 Closed
Nomura Holdings
197
Nomura Holdings
Japan
– -$96K -24 Closed
BNP Paribas Financial Markets
198
BNP Paribas Financial Markets
France
– -$85.2K -21 Closed
JG
199
Jefferies Group
New York
– -$70K -17 Closed
SFU
200
Stonehage Fleming (UK)
United Kingdom
– -$12K -3 Closed
5 6 7
8
9

ACOR Hedge Fund Activity: Q4 2014 in Review

179 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2014, worth a combined $1.81B — up 19% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 20 closed out — a net gain of 6 holders — while 55 added to existing stakes and 68 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $18.8M. The largest seller was Oracle Investment Management, cutting an estimated $29.3M.

  • 179 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2014, up from 174 in Q3 2014.
  • Funds reported $1.81B of Acorda Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q4 2014 and 20 closed out, a net change of +6 holders.
  • The largest Acorda Therapeutics buyer in Q4 2014 was Wellington Management Group, an estimated $18.8M added.
  • The largest Acorda Therapeutics seller in Q4 2014 was Oracle Investment Management, an estimated $29.3M sold.

Based on aggregated 13F filings for Q4 2014.